Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pabron
- Development stage
- Unknown
- Lead developer
- Taisho Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Pabron is a widely recognized brand of over-the-counter (OTC) cold and cough medications developed and manufactured by Taisho Pharmaceutical Co., Ltd. in Japan. The product line consists of multi-ingredient small molecule combinations designed to provide comprehensive relief for a variety of common cold symptoms, including fever, cough, sputum, sore throat, and nasal congestion. A representative formulation, Pabron Gold A, contains seven active ingredients: acetaminophen (analgesic/antipyretic), dihydrocodeine phosphate (cough suppressant), guaifenesin (expectorant), dl-methylephedrine hydrochloride (bronchodilator), chlorpheniramine maleate (antihistamine), anhydrous caffeine, and riboflavin (vitamin B2). These medications are available in several dosage forms, including tablets and granules, and are among the most popular consumer health products for respiratory ailments in the Japanese market.
- Brand names
- PabronPabron Gold APabron S Gold WPabron Ace Pro
02
Targets
ADRB2 (β2)ADORA2A (Adenosine A₂A Receptor)MOR (Mu opioid receptor)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)HRH1 (Histamine H1 Receptor)ADORA1 (Adenosine receptor A1 subtype)
Beyond the preview
Go deeper on Pabron.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pabron.